Thought Leadership

Our leading subject matter experts share their insightful analysis and points of view to help you stay abreast of industry trends

Cracking the Code of BIN/PCN/Group Data for Faster Benefit Verification

September

25

2025

As patient access grows more complex, manufacturers need tools that reduce friction throughout the care journey. One valuable but frequently overlooked dataset is known as BIN/PCN/Group (BPG) data, which refers to a trio of identifiers used in pharmacy claims processing.

Unlocking the power of BPG data can transform claims bridging and streamline early benefit verification, helping pharma companies provide support to more patients in need.

What Is BPG Data, and Why Is It Elusive? 

A patient’s drug benefit insurance card features their name, member ID, and plan group name—which is assigned by the payer, and does not necessarily correspond to PBM naming conventions. Three essential numbers are also encoded in the card’s magnetic strip:

  • Rx BIN (prescription Bank Identification Number): This six-digit number identifies the specific insurance company or PBM processing the claim.
  • Rx PCN (Processor Control Number): This alphanumeric code identifies the specific benefit package within a payer.
  • Rx Group Number: This identifier points to the plan benefit structure within the payer, which indicates the correct coverage and pricing. Typically, this number identifies an employer, but it can also be a contract number for Medicare and Medicaid patients. Neither of these identifiers are easy to find or map, as CMS does not publish its contract ID numbers.

In order to route a pharmacy claim to the correct adjudication system, a pharmacy technician needs four pieces of information: the patient’s member ID plus their BPG numbers. Together, this data enables accurate claims processing, routing and coverage identification.

As there is no master database of all BPG numbers, many duplicates exist among adjudication systems and PBMs, which means that the same Rx Group number can be associated with several different BIN/PCN combinations. This complicates the plan matching process — especially for manufacturers, hubs, and support teams working directly with patients.

Read the full article in Drug Channels. 

Learn more about MMIT’s Bridging as a Service, which maps various source IDs to our payer data backbone, providing clients with a single source of truth for ingestion or API delivery.

 

Carolyn Zele

Carolyn Zele

As a solution consultant for MMIT, Carolyn Zele helps pharmaceutical manufacturers simplify market access and prepare for launch success. Prior to MMIT, Carolyn spent numerous years in the payer/PBM space managing formulary teams and technology across both regulated and non-regulated lines of business.

Related Post
How Copay Accumulators and Maximizers Affect Pharma PAPs
April 10

How Copay Accumulators and Maximizers Affect Pharma PAPs

Read More
Market Access Trends Impacting Your Patient Assistance Program
February 13

Market Access Trends Impacting Your Patient Assistance Program

Read More
Featured
Emerging-Treatments-Offer-New-Hope-Alcohol-Use-Disorder

Emerging Treatments Offer New Hope for Alcohol Use Disorder

Key-Takeaways-Rare-Disease-Commercialization

Competitive ATTR Dynamics: Key Takeaways for Rare-Disease Commercialization

Alternative-Funding-Programs

Alternative Funding Programs: Short-Term Savings, Long-Term Consequences

Topics

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

Stay In Touch

Be the first to know about new arrivals and promotions

Reducing Risk: 5 Steps for a Fearless Launch